Infoscience

Journal article

Specificity and mechanism-of-action of the JAK2 tyrosine kinase inhibitors ruxolitinib and SAR302503 (TG101348)

    Note:

    Letter

    Reference

    Record created on 2013-09-30, modified on 2016-08-09

Fulltext

Related material